Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Completed 4Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1

Conditions

Quality of Recovery 1Prostatic Neoplasms 1Myofibroma 1Endobronchial Metastases 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × OTHER × remimazolam × Clear all
NCT06093971 2024-12-12

Remimazolam Versus Propofol for General Anesthesia Induction in Patients on Renin-angiotensin System Blockers Undergoing Robot-assisted Laparoscopic Prostatectomy

Yonsei University

Phase NA Completed
112 enrolled
Genitourinary

Prostatic Neoplasms

NCT05356091 2023-03-09

Quality of Recovery of Remimazolam Versus Sevoflurane in Transurethral Bladder Resection.

Kangbuk Samsung Hospital

Phase NA Completed
36 enrolled

Quality of Recovery

NCT05468671 2022-10-26

Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy

Zhejiang Cancer Hospital

Phase 4 Completed
34 enrolled
GastrointestinalThoracic

Endobronchial Metastases

NCT05025410 2022-04-25

Remimazolam and Remifentanil Without Neuromuscular Blocking Agent

Seoul National University Bundang Hospital

Completed
38 enrolled

Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡